What is the most common complication of Giant cell arteritis?
A 25-year-old woman presents with a 2-week history of febrile illness and chest pain. She has an erythematous, macular facial rash and tender joints, particularly in her left wrist and elbow. A CBC shows mild anemia and thrombocytopenia. Corticosteroids are prescribed for the patient. This medication induces the synthesis of an inhibitor of which of the following enzymes in inflammatory cells?
Which radiological feature helps differentiate rheumatoid arthritis from SLE?
A previously healthy and active 72-year-old woman presents with stiffness and pain in her neck and shoulders. The symptoms are much worse in the morning and improve throughout the day. The pain affects the soft tissues and is not localized to the shoulder or hip joints. She denies headache or jaw claudication. Physical examination reveals normal muscle strength and range of motion of the shoulder and hip joints, with no inflammatory synovitis, muscle tenderness, or skin rash. Laboratory studies show an elevated ESR of 92 mm/h and a mild normocytic anemia. What is the best next step in management?
A patient presents with recurrent oral ulcers. The ulcers are small with a yellow floor surrounded by an erythematous halo on the lips. The patient also has multiple, tender nodules on the shins. What is the probable diagnosis?
Which of the following is not typically seen in Henoch-Schonlein purpura?
Treatment of Behcet's syndrome consists of:
What is the drug of choice in scleroderma-induced hypertensive crisis?
A 48-year-old man presents with 3 weeks of fever, fatigue, and shortness of breath. He has a history of nasal allergies and asthma, which have been poorly controlled in the past month. Two days prior to presentation, he developed weakness in his left foot and it now drags when he walks. On examination, his blood pressure is 165/90 mm Hg, pulse 100/min, respirations 20/min, and lungs have bilateral expiratory wheezes. There is left foot drop, and the rest of the neurologic examination is normal. Laboratory evaluation reveals ESR of 90 mm/h, WBC of 14,000/mL with 10% eosinophils, and 1+ proteinuria. A CXR shows bilateral pulmonary infiltrates. For the above patient with a vasculitis syndrome, what is the most likely diagnosis?
All may be true about Rheumatoid Arthritis except?
Explanation: **Explanation:** **Giant Cell Arteritis (GCA)**, also known as temporal arteritis, is a large-vessel vasculitis that primarily affects the branches of the external carotid artery. **Why Blindness is the Correct Answer:** The most feared and common serious complication of GCA is **permanent visual loss (blindness)** [1]. This occurs due to **Anterior Ischemic Optic Neuropathy (AION)**, caused by vasculitis and subsequent occlusion of the **posterior ciliary arteries** (branches of the ophthalmic artery). This leads to ischemia of the optic nerve head. It is often preceded by *amaurosis fugax* (transient monocular vision loss) and is considered a medical emergency requiring immediate high-dose corticosteroids to prevent bilateral involvement [1]. **Why Other Options are Incorrect:** * **A. Stroke:** While GCA can involve the carotid or vertebral arteries leading to a CVA, it is significantly less common than visual complications. * **B. Myocardial Infarction (MI):** Although GCA is an inflammatory state that can theoretically accelerate atherosclerosis, it is not a classic or frequent complication of the disease. * **D. Renal Failure:** GCA is a large-vessel vasculitis. Renal involvement (glomerulonephritis) is characteristic of small-vessel vasculitides (like GPA or MPA) but is **not** a feature of GCA [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Demographics:** Almost exclusively occurs in patients **>50 years** of age. * **Association:** Strongly associated with **Polymyalgia Rheumatica (PMR)** in 50% of cases [1]. * **Diagnosis:** Gold standard is **Temporal Artery Biopsy** (look for "skip lesions" and granulomatous inflammation) [1]. * **Lab Marker:** Characteristically high **ESR** (>50 mm/hr, often >100) [1]. * **Management:** Do **not** wait for biopsy results to start treatment. If GCA is suspected, start high-dose IV/Oral steroids immediately to prevent irreversible blindness [1].
Explanation: ### Explanation **Clinical Correlation:** The patient presents with classic features of **Systemic Lupus Erythematosus (SLE)**: malar rash, polyarthritis (wrist/elbow), serositis (chest pain/pleuritis), and cytopenias (anemia/thrombocytopenia) [1]. Corticosteroids are the mainstay of treatment for acute flares. **Why Phospholipase A2 (PLA2) is the correct answer:** Corticosteroids exert their anti-inflammatory effect primarily by inducing the synthesis of **Annexin A1 (also known as Lipocortin-1)**. Annexin A1 directly **inhibits Phospholipase A2**. * **Mechanism:** PLA2 is the enzyme responsible for releasing arachidonic acid from membrane phospholipids. By inhibiting PLA2, steroids block the entire arachidonic acid cascade, preventing the production of both **prostaglandins** (via the COX pathway) and **leukotrienes** (via the LOX pathway). This dual inhibition makes steroids more potent anti-inflammatory agents than NSAIDs. **Why other options are incorrect:** * **A. Lipoxygenase (LOX):** While steroids eventually decrease leukotriene levels, they do not directly induce an inhibitor of LOX. LOX is inhibited by drugs like Zileuton. * **B. Myeloperoxidase (MPO):** This enzyme is found in neutrophil granules and produces hypochlorous acid. It is not the primary target of corticosteroid-induced proteins. * **D. Superoxide dismutase (SOD):** This is an antioxidant enzyme that neutralizes superoxide radicals. Steroids do not work by inducing an inhibitor of SOD. **NEET-PG High-Yield Pearls:** * **Annexin A1 (Lipocortin-1):** The specific protein induced by steroids to inhibit PLA2. * **Genomic vs. Non-genomic:** Steroids act via cytosolic receptors that translocate to the nucleus to alter gene transcription. * **IκB Induction:** Steroids also induce **IκB** (an inhibitor of NF-κB), which keeps the pro-inflammatory transcription factor NF-κB sequestered in the cytoplasm, further reducing cytokine production (IL-1, TNF-α) [2].
Explanation: The key radiological distinction between Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) lies in the **erosive nature** of the joint involvement. ### **Explanation of the Correct Answer** * **Erosion (Option A):** Rheumatoid arthritis is characterized by chronic synovial inflammation (pannus formation), which leads to the destruction of bone and cartilage, resulting in **marginal erosions** [1]. In contrast, SLE is typically a **non-erosive** arthritis. While SLE can cause significant deformities (like Jaccoud’s arthropathy), the underlying bone remains intact on X-ray. ### **Analysis of Incorrect Options** * **Juxta-articular osteoporosis (Option B):** This is an early radiological sign of RA due to localized cytokine release and hyperaemia [2], but it can also be seen in other inflammatory arthritides, including SLE, and is therefore not a definitive differentiating feature. * **Subluxation of the MCP joint (Option C):** Both RA and SLE can present with ulnar deviation and subluxation. In SLE, this is known as **Jaccoud’s arthropathy**, which is unique because the deformities are **reducible** and occur due to ligamentous laxity rather than joint destruction. * **Swelling of the PIP joint (Option D):** Soft tissue swelling is a non-specific sign of active inflammation (synovitis) common to both conditions during an acute flare [3]. ### **NEET-PG High-Yield Pearls** * **RA Hallmark:** Symmetric, small joint involvement with marginal erosions and joint space narrowing [2]. * **SLE Hallmark:** Migratory, non-erosive polyarthritis. If deformities are present without erosions, think **Jaccoud’s Arthropathy**. * **Most common joint in RA:** MCP and PIP joints (DIP joints are typically spared) [3]. * **First radiological sign of RA:** Soft tissue swelling, followed by juxta-articular osteopenia.
Explanation: ### Explanation The clinical presentation is classic for **Polymyalgia Rheumatica (PMR)**. This inflammatory condition typically affects patients over 50 and is characterized by subacute onset of bilateral pain and morning stiffness (lasting >45 minutes) in the neck, shoulder girdle, and pelvic girdle [1]. **1. Why Option A is Correct:** The diagnosis of PMR is primarily clinical, supported by an elevated ESR (often >40–50 mm/h) [1]. A hallmark of PMR is the **dramatic, rapid response** (usually within 24–72 hours) to low-dose corticosteroids (10–20 mg prednisone daily). Given the patient’s age, high ESR, and classic distribution of symptoms without muscle weakness, an empiric trial of prednisone is both diagnostic and therapeutic. **2. Why the Other Options are Incorrect:** * **B. Graded exercise regimen:** While useful for fibromyalgia or osteoarthritis, it does not address the underlying systemic inflammation of PMR and will not lower the ESR. Management of muscle diseases generally includes physiotherapy to maximize function [1]. * **C. MRI of bilateral shoulders:** While MRI might show subdeltoid bursitis (common in PMR), it is expensive and unnecessary. Diagnosis is based on clinical criteria and response to steroids. * **D. Trapezius muscle biopsy:** This is used to diagnose inflammatory myopathies (e.g., polymyositis) [1]. However, this patient has **normal muscle strength** and no muscle tenderness, making myositis unlikely. **3. NEET-PG High-Yield Pearls:** * **PMR vs. Polymyositis:** PMR presents with **pain/stiffness** and normal CK levels; Polymyositis presents with **painless proximal weakness** and elevated CK levels [1]. * **Association:** Approximately 15–20% of PMR patients develop **Giant Cell Arteritis (GCA)**. Always screen for headache, jaw claudication, or visual loss. * **Lab Findings:** Elevated ESR/CRP and normocytic anemia (anemia of chronic disease) are common. * **Treatment:** Low-dose steroids (10–20 mg) for PMR; high-dose steroids (40–60 mg) if GCA is suspected.
Explanation: ### Explanation **Correct Answer: B. Behcet's syndrome** Behcet’s syndrome is a chronic, multisystemic, relapsing inflammatory perivasculitis. The diagnosis is primarily clinical, based on the **International Study Group criteria**. * **Oral Ulcers:** These are the hallmark and usually the first symptom. They are typically painful, recurrent, and appear as aphthous ulcers (yellow base with an erythematous halo). * **Skin Lesions:** The "tender nodules on the shins" describe **Erythema Nodosum**, a common cutaneous manifestation of Behcet’s. Other skin findings include pseudofolliculitis and acneiform eruptions. * **Systemic Involvement:** The combination of recurrent oral ulcers plus systemic signs (like skin nodules, genital ulcers, or uveitis) strongly points toward Behcet’s. **Why the other options are incorrect:** * **A. Pemphigus vulgaris:** An autoimmune blistering disease characterized by fragile, flaccid bullae and erosions. While it involves oral mucosa, it does not typically present with Erythema Nodosum. * **C. Herpes Labialis:** Caused by HSV-1, these present as clusters of small vesicles on an erythematous base ("dewdrops on a rose petal"), usually localized to the vermilion border, rather than recurrent aphthous-like ulcers with systemic nodules. * **D. Fixed drug eruption:** Presents as a solitary (or few) dusky red/violaceous macule that recurs at the *exact same site* upon re-exposure to a specific drug. It does not explain the systemic nodules on the shins. **High-Yield Pearls for NEET-PG:** 1. **Pathergy Test:** A unique diagnostic test for Behcet’s where a sterile needle prick causes a papule/pustule within 24–48 hours (highly specific). 2. **HLA Association:** Strongly associated with **HLA-B51**. 3. **Triad:** Historically known as the triad of oral ulcers, genital ulcers, and uveitis (hypopyon). 4. **Vascular:** It is one of the few vasculitides that involves both **arteries and veins** of all sizes.
Explanation: **Explanation:** Henoch-Schönlein Purpura (HSP), now commonly referred to as **IgA Vasculitis**, is a small-vessel vasculitis characterized by the deposition of immune complexes containing **Immunoglobulin A (IgA)** [1]. **Why Thrombocytopenia is the correct answer:** The hallmark of HSP is **non-thrombocytopenic purpura**. Unlike conditions like ITP or TTP where bruising occurs due to low platelet counts, the purpura in HSP is caused by inflammation of the blood vessel walls (leukocytoclastic vasculitis) leading to extravasation of RBCs. Therefore, the **platelet count in HSP is typically normal or even elevated** (as an acute-phase reactant). Finding thrombocytopenia should prompt a clinician to look for alternative diagnoses. **Why the other options are incorrect:** * **Glomerulonephritis (B):** Renal involvement occurs in about 40-50% of cases, presenting as hematuria or proteinuria. It is histologically identical to IgA Nephropathy (Berger’s disease). * **Arthralgia (C):** Migratory polyarthralgia, typically affecting the knees and ankles, is seen in ~75% of patients. It is non-deforming. * **Abdominal pain (D):** Colicky abdominal pain due to bowel wall edema and hemorrhage is common [1]. It can lead to complications like **intussusception** (typically ileo-ileal). **High-Yield Clinical Pearls for NEET-PG:** * **Classic Tetrad:** Palpable purpura (without thrombocytopenia), arthritis/arthralgia, abdominal pain, and renal disease. * **Demographics:** Most common vasculitis in children; often follows an Upper Respiratory Tract Infection (URTI). * **Diagnosis:** Primarily clinical. Biopsy shows **IgA deposition** on immunofluorescence. * **Treatment:** Mostly supportive; steroids are used for severe gastrointestinal or renal involvement.
Explanation: Behcet’s syndrome is a multisystemic, chronic relapsing inflammatory perivasculitis. The treatment strategy is tailored to the specific clinical manifestations (mucocutaneous, ocular, vascular, or neurological). **Why Aspirin is the correct answer:** In the context of Behcet’s syndrome, **Aspirin** is frequently utilized for its antiplatelet and anti-inflammatory properties. Since Behcet’s is characterized by a high risk of **venous and arterial thrombosis** (due to endothelial inflammation rather than a primary prothrombotic state), low-dose aspirin is often prescribed as a prophylactic measure to prevent vascular complications. While corticosteroids are used for acute flares, aspirin remains a staple for long-term management of the associated vasculopathy. **Analysis of Incorrect Options:** * **Vincristine:** This is a microtubule inhibitor used primarily in chemotherapy (leukemias/lymphomas). It has no established role in the management of Behcet’s syndrome. * **Glucocorticoids:** While steroids are used to treat acute inflammatory episodes (like uveitis or major organ involvement), they are generally considered "rescue" or "adjunctive" therapy rather than the definitive treatment for the underlying syndrome itself. In many MCQ formats, if a single drug for vascular protection/maintenance is sought, aspirin is prioritized. * **Thalidomide:** Though used for refractory orogenital ulcers in Behcet’s, it is not the primary treatment due to its severe teratogenic profile and neurotoxicity. **NEET-PG High-Yield Pearls:** * **Classic Triad:** Recurrent oral ulcers, genital ulcers, and uveitis. * **Pathergy Test:** A unique diagnostic feature where a sterile papule/pustule forms 24–48 hours after a skin prick. * **HLA Association:** Strongly linked with **HLA-B51**. * **Vascular Involvement:** It is one of the few vasculitides that involves both arteries and veins (venous thrombosis is common). * **Drug of Choice for Mucocutaneous lesions:** Colchicine. * **Drug of Choice for Uveitis/CNS involvement:** Azathioprine, Cyclosporine, or Anti-TNF agents (Infliximab).
Explanation: **Explanation:** **Scleroderma Renal Crisis (SRC)** is a life-threatening complication of systemic sclerosis characterized by malignant hypertension and rapid-onset renal failure. **Why ACE inhibitors are the Drug of Choice:** The underlying pathophysiology of SRC involves excessive activation of the **Renin-Angiotensin-Aldosterone System (RAAS)**. Intimal proliferation in the renal arteries leads to renal ischemia, which triggers a massive release of renin. **ACE inhibitors (specifically Captopril)** are the gold standard because they directly counteract this mechanism by blocking the conversion of Angiotensin I to Angiotensin II [1]. Even if the patient’s serum creatinine is elevated, ACE inhibitors must be started immediately as they are life-saving and can stabilize or even improve renal function [1]. **Why other options are incorrect:** * **Thiazides:** These can cause volume depletion, which further activates the RAAS, potentially worsening the renal crisis. * **Beta-blockers:** These are generally avoided in scleroderma as they can exacerbate **Raynaud’s phenomenon** due to unopposed alpha-adrenergic vasoconstriction. * **Sodium nitroprusside:** While it can lower blood pressure, it does not address the primary RAAS-driven mechanism of SRC and is reserved only for refractory cases with hypertensive encephalopathy. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Captopril (short-acting, allowing for rapid titration). * **Risk Factor:** High-dose **Corticosteroids** (>15mg/day of prednisolone) are a major trigger for SRC. * **Prognosis:** Approximately 25% of patients may still require dialysis, but early ACE inhibitor therapy allows some to recover enough renal function to discontinue dialysis later. * **Antibody Association:** Anti-RNA polymerase III antibodies are strongly associated with an increased risk of SRC.
Explanation: The patient presents with a classic triad of **asthma, peripheral eosinophilia, and systemic vasculitis**, which is diagnostic of **Eosinophilic Granulomatosis with Polyangiitis (EGPA)**, formerly known as **Churg-Strauss disease** [1]. ### Why Churg-Strauss is Correct: The clinical picture follows the three phases of EGPA: 1. **Prodromal Phase:** History of asthma and allergic rhinitis [2]. 2. **Eosinophilic Phase:** Peripheral blood eosinophilia (10% in this case) and pulmonary infiltrates [1]. 3. **Vasculitic Phase:** Small-to-medium vessel vasculitis manifesting here as **mononeuritis multiplex** (left foot drop) and renal involvement (proteinuria/hypertension) [1]. The elevated ESR and constitutional symptoms (fever, fatigue) further support a systemic inflammatory process [3]. ### Why Other Options are Incorrect: * **Polyarteritis nodosa (PAN):** While PAN causes mononeuritis multiplex and hypertension, it characteristically **spares the lungs** and is not associated with asthma or significant eosinophilia [2]. * **Henoch-Schonlein purpura (IgA Vasculitis):** Typically presents in children with a tetrad of palpable purpura, arthritis, abdominal pain, and renal disease [1]. It is not associated with asthma or eosinophilia. * **Vasculitis associated with infectious diseases:** While infections (like Hepatitis B) can trigger vasculitis, the specific combination of asthma and eosinophilia points strongly toward a primary autoimmune vasculitis like EGPA. ### NEET-PG High-Yield Pearls: * **ANCA Status:** Approximately 40-60% of EGPA patients are **p-ANCA (anti-MPO) positive**, especially those with renal involvement [1]. * **Biopsy Gold Standard:** Shows necrotizing vasculitis with **extravascular granulomas** and eosinophilic tissue infiltration [2]. * **Cardiac Involvement:** This is the leading cause of mortality in EGPA (e.g., eosinophilic myocarditis). * **Treatment:** High-dose corticosteroids are the mainstay; cyclophosphamide is added for severe organ involvement [1].
Explanation: **Explanation:** The correct answer is **D (Anti-Mi-2 antibody)** because this antibody is a highly specific marker for **Dermatomyositis**, not Rheumatoid Arthritis (RA). Anti-Mi-2 is directed against a helicase enzyme involved in transcriptional activation and is classically associated with the hallmark skin manifestations of dermatomyositis, such as Gottron papules and Heliotrope rash, often indicating a good prognosis. **Analysis of other options:** * **A. Anti-MCV assay:** Anti-Mutated Citrullinated Vimentin (MCV) is a newer biomarker for RA. It has a diagnostic sensitivity and specificity comparable to or sometimes higher than Anti-CCP, especially in early RA. * **B. RF positive:** Rheumatoid Factor (an IgM antibody against the Fc portion of IgG) is the classic screening test for RA [1]. While found in 70-80% of patients, it is less specific than Anti-CCP as it can be positive in other connective tissue diseases and chronic infections [1]. * **C. Anti-CCP antibody:** Anti-Cyclic Citrullinated Peptide is the most specific (95-98%) diagnostic marker for RA [1]. Its presence is a strong predictor of erosive joint disease and is included in the ACR/EULAR classification criteria [1]. **Clinical Pearls for NEET-PG:** * **Most Specific Marker for RA:** Anti-CCP [1]. * **Best Initial Test for RA:** Rheumatoid Factor (RF) [1]. * **Poor Prognostic Factors in RA:** High titers of RF/Anti-CCP, presence of HLA-DR4, and early erosions on X-ray [1]. * **Anti-Jo-1:** The most common anti-synthetase antibody in Polymyositis/Dermatomyositis, associated with interstitial lung disease (ILD) and "Mechanic's hands."
Rheumatoid Arthritis
Practice Questions
Spondyloarthropathies
Practice Questions
Systemic Lupus Erythematosus
Practice Questions
Vasculitis Syndromes
Practice Questions
Scleroderma and Related Disorders
Practice Questions
Inflammatory Myopathies
Practice Questions
Crystal Arthropathies
Practice Questions
Osteoarthritis
Practice Questions
Primary Immunodeficiency Disorders
Practice Questions
Autoinflammatory Syndromes
Practice Questions
Sjögren's Syndrome
Practice Questions
Antiphospholipid Syndrome
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free